[144] Crinetics Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Crinetics Pharmaceuticals (CRNX) filed a Form 144 reporting a proposed sale of 6,492 common shares valued at $191,059.56 with an approximate sale date of 08/20/2025 on NASDAQ. The filing lists total shares outstanding of 94,175,994. The securities were acquired as 4,360 restricted stock units on 03/15/2025 and 2,132 shares through an employee stock purchase plan on 05/20/2023. The filer reports no securities sold in the past three months. Several standard filer contact and issuer identification fields in the provided content are blank or not provided.

Insights

Financial Analyst

TL;DR Insider plans to sell a small block of shares disclosed under Rule 144; size is immaterial relative to the company's shares outstanding.

The Form 144 shows a proposed sale of 6,492 common shares worth $191,059.56 against 94,175,994 shares outstanding, representing an immaterial percentage of the float. The holdings were acquired primarily via restricted stock units and an ESPP. No sales in the prior three months are reported, and key filer/issuer contact fields are missing in the provided text. This disclosure enhances transparency but does not indicate material dilution or a meaningful change to capital structure.

Corporate Governance Expert

TL;DR The filing meets Rule 144 disclosure by reporting proposed insider sale details, though some identifying fields are absent in the supplied content.

Crinetics’ notice provides transaction-specific details required for Rule 144 compliance including class, broker, acquisition method, and planned sale date. The omission of filer CIK/contact and issuer identification in the provided excerpt limits third-party verification. From a governance perspective, the form itself is a routine compliance filing and does not, on its face, signal governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6492	191059.56	94175994	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2025	Restricted Stock Units	Issuer			4360	03/15/2025	N/A
Common	05/20/2023	Employee Stock Purchase Plan	Issuer			2132	05/20/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)